Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Nov 10, 2011; 2(11): 367-376
Published online Nov 10, 2011. doi: 10.5306/wjco.v2.i11.367
Published online Nov 10, 2011. doi: 10.5306/wjco.v2.i11.367
Figure 1 Molecular mechanisms through the Epidermal Growth Factor Receptor pathway.
This figure shows EGFR ligands binding with their receptor and triggering mechanisms toward downstream intracellular signaling throughout the PLCγ, PI3K, Ras/Raf/MEK/ERK, STATs pathways leading to proliferation, metastasis, autocrine feedback, and survival (Adapted from reference 7 with permission). EGFR: Epidermal growth factor receptor; Shc: Src homologous and collagen protein; PCL-γ: Phospholipase Cγ; PI3K: Phosphatidylinositol 3-kinase; STATs: Signal transducer and activator of transcriptions; PKC: Protein kinase C; Grb2: Growth factor receptor bound protein 2; SOS: Guanine nucleotide exchange factor sos; MAPK:mitogen-activated protein kinase
- Citation: Mello RA, Marques DS, Medeiros R, Araújo AM. Epidermal growth factor receptor and K-Ras in non-small cell lung cancer-molecular pathways involved and targeted therapies. World J Clin Oncol 2011; 2(11): 367-376
- URL: https://www.wjgnet.com/2218-4333/full/v2/i11/367.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i11.367